A Bottom-Basement Lithium Entry Point for Investor Opportunity: Elektros Inc., a Lithium Mining Company, Advances Strategic Communications
accessnewswire.com
Want to monitor VIR?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VIRVir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.